None listed
Conditions
Interventions
Intervention1: Hair Removal Cream -: For Day 1 to 7
Step-1 Apply directly onto the skin with a spatula’s wide base and spread the cream evenly to fully cover the hair.
Step-2 Wait for 3-6 minutes & th
Sponsors
Visage Lines Personal Care Private Limited
Eligibility
Inclusion criteria
Inclusion criteria: 1) Age - 18 to 35 years (both inclusive) old at the time of consent. 2) Sex - Healthy human non-pregnant/non-lactating females 3) Frequent user of hair removal cream 4) Females of childbearing potential must have a negative urine pregnancy test performed on Day 01 before application, and agree to follow an accepted method of birth control for the duration of the study such as condoms, foams, jellies, diaphragm, intrauterine device etc. 5) Subjects are generally in good general health as determined from recent medical history. 6) The subject does not have any previous history of adverse skin conditions and is not under any medication likely to interfere with the results. 7) The subjects who have not waxed or removed their limbs for more than 10 days and who regularly depilator their limbs using hair removal cream. 8) The subject is willing and able to follow the study directions, participate in the study, returning for all specified visits. 9) The subject must be able to understand and provide written informed consent to participate in the study.
Exclusion criteria
Exclusion criteria: 1) Subject with known allergy or sensitization to product ingredients such urea, paraffinum liquidum, cetearyl alcohol, acrylates copolymer, potassium thioglycolate, calcium hydroxide, talc, ceteareth-20, glycerin, sorbitol, magnesium trisilicate, propylene glycol, lithium magnesium sodium silicate, sodium gluconate, tocopheryl acetate, Aloe Barbadensis (Aloe Vera) leaf extract, butylphenyl methylpropional, allantoin, bisabolol, Butyrospermum Parkii (Shea Butter), Fragrance or any other ingredients. 2) The subject has skin irritation, open wounds, cuts, abrasions, irritation symptoms or any on application sites. 3) The subject has skin irritation, blemishes, moles, pigmentation, pimples, marks [e.g. tattoos (within the previous 3 months), scars, sunburn], open wounds, cuts, abrasions, irritation symptoms or any dermatological condition on the test site(s) i.e. back that can interfere with the reading. 4) Medication which may affect skin response and/or past medical history. 5) The subject has a history of diabetes. 6) The subject has a history of mastectomy for cancer involving removal of lymph nodes within the past year, or treatment of any type of cancer within the last 6 months. 7) The subject suffering from any active clinically significant skin diseases which may contraindicate. 8) The subject has a history of any skin diseases including eczema, atopic dermatitis or active cancer. 9) The subject has a history of asthma or COPD (Chronic obstructive pulmonary disease). 10) Topical drugs used at the application site. 11) Subject with Self-reported Immunological disorders such as HIV positive, AIDS and/or systemic lupus erythematosus. 12) An individual who has a medical condition or is taking or has taken a medication which, in the Investigator’s judgment, makes the subject ineligible or places the subject at undue risk. 13) Participation in other clinical studies simultaneously.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate the effectiveness of the test product on skin colour, and tone using Skin ColorimeterTimepoint: Baseline Day 01 before application, at 30 mins after product removal on Day 01 and Day 07 | — |
Secondary
| Measure | Time frame |
|---|---|
| To assess the effect of the test product in terms of local irritation (erythema, scaling, itching, and burning) fromTimepoint: Baseline Day 01 before application, after product removal on Day 01 and Day 07;To assess the effect of the test product in terms of product perception about moisturising feel, pain, change of skin colour, smoothness post usage, the fragrance of the product, the effectiveness of hair removalTimepoint: on Day 01 and 07 after product usage;To evaluate the effectiveness of the test product in terms of complete removal of hair, pain, dirt and tan removal, smoothness of skin, dryness, roughness, signs of itching, redness, burning, papular response on the skinTimepoint: Baseline Day 01 before application, after product removal on Day 01 and Day 07 | — |
Countries
India
Contacts
Public ContactMaheshvari Patel
NovoBliss Research Private Limited
Outcome results
None listed